About MARS Bioimaging Ltd
MARS Bioimaging Ltd (MBI) is an award winning manufacturer of small bore spectral CT scanners for pre-clinical medical research. The company was formed in 2007 to commercialize the ground-breaking MARS technology. MBI brings together an interdisciplinary R&D team of physicists, radiologists, engineers, computer scientists, orthopaedic and other surgeons, mathematicians, biologists, and cancer researchers.
The MARS system is based on the next generation of x-ray detectors (Medipix3RX) developed in collaboration with CERN, University of Canterbury, University of Otago, and other partners. MBI has established itself as the world’s leading research and development group in spectral molecular imaging and to-date has delivered the world’s first commercial pre-clinical small bore spectral scanner.
The MARS small bore scanner enables customers to conduct experiments in a system that is directly translatable to human imaging. MBI works closely with customers to provide a wide range of spectral imaging solutions for applications ranging from cancer detection to development of novel contrast agents.
Contact us to find out how MARS spectral imaging can improve your research.
Chief Executive Officer
Professor Phil Butler is a co-founder of MARS Bioimaging Ltd. Phil
Chief Medical Officer
Professor Anthony Butler is a clinical radiologist with an interest in developing new imaging technologies. He is a co-founder of MARS Bioimaging Ltd. He is the lead investigator on over $12m of NZ government research grants, and co-investigator on more than $30m of other grants. At the University of Otago, Christchurch, he is head of the Department of Radiology. At CERN, he is a member of the Medipix3, Medipix4, and CMS collaborations.
Director
Colin Dawson is a member of the board of MARS Bioimaging Ltd. He was a founding partner in health consulting and investment banking services firm Medicus Capital. Colin is a former director of the NZX-listed companies BLIS Technologies and Pacific Edge, and former Trustee of the Upstart Business Incubator. His interests are the commercialisation of Intellectual Property and the effective governance of technology-based businesses and companies where disruptive technology is bringing change to the existing competitive landscape.
Commercial Manager
Stuart Lansley is experienced in technology commercialisation and investment, having previously been involved in the commercialisation of university intellectual property at Powerhouse Ventures. Prior to this, he was a lecturer in Electrical Engineering and researcher in Medical Physics at the University of Canterbury, during which he became involved in the MARS Programme. Stuart has an MEng in Engineering & Materials Science from the University of Oxford and a PhD in Electrical & Electronic Engineering from University College London. As Commercial Manager, Stuart leads many of the commercial and operational activities of MBI.
Business Development Manager
Vivek Nair is a management graduate with 18 years’ experience in business development. He has previously worked with top multinational corporations in the medical and commercial banking sectors. He also was instrumental in commercial development of several start-ups. Vivek leads the development of strategic alliances, including international bilateral partnerships, as well as leading the sales and marketing of our commercial products.
Awards
HealthTech Award for Best Translational Project – HealthTech Week 2019
Finalist in Best Hardware Product category – NZ Hi-Tech Awards 2018
Winner of Best Emerging New Zealand Innovation – New Zealand Innovation Awards 2017
Winner of Best Innovation in Health and Science – New Zealand Innovation Awards 2017
Winner of the Supreme Award (Small Enterprise) – Champion Canterbury Business Awards 2017
Winner of Champion Innovation – Champion Canterbury Business Awards 2017
Winner of Champion Producer/Manufacturer (Small Enterprise) – Champion Canterbury Business Awards 2017
